Biden admin reaches deal with drugmakers to cut Medicare prescription costs

THE WHITE HOUSE ANNOUNCED WEDNESDAY NIGHT FEDERAL OFFICIALS HAD COME TO AN AGREEMENT WITH DRUG COMPANIES… TO LOWER THE PRICES OF MEDICARE’S TEN MOST POPULAR – AND EXPENSIVE – PRESCRIPTIONS. 

THEY SAID THE LOWER PRICES SHOULD SAVE TAXPAYERS AROUND 6 BILLION DOLLARS… WHILE OLDER AMERICANS COULD SAVE ROUGHLY 1.5 BILLION ON THEIR MEDICATIONS. 

THE WHITE HOUSE SAYS THIS DEAL WILL IMPACT THE PRICE OF DRUGS USED BY MILLIONS TO HELP MANAGE DIABETES AND BLOOD CANCERS, AND PREVENT HEART FAILURE OR BLOOD CLOTS. 

SOME OF THE DRUGS THAT WILL SEE A PRICE DROP INCLUDE THE BLOOD THINNERS XARELTO AND ELIQUIS… AND DIABETES DRUGS JARDIANCE AND JANUVIA.

LAST YEAR – MEDICARE SPENT 50 BILLION DOLLARS COVERING THOSE FOUR MEDICATIONS ALONE. 

THE NEW PRICING IS SET TO TAKE EFFECT FOR THOSE WITH MEDICARE PART D COVERAGE IN JANUARY OF 20-26.

THIS DEAL WILL BE THE FOCUS OF THURSDAY’S JOINT APPEARANCE OF PRESIDENT JOE BIDEN AND VICE PRESIDENT KAMALA HARRIS.

THIS WILL BE THEIR FIRST PUBLIC EVENT TOGETHER SINCE THE PRESIDENT ANNOUNCED HE WAS ENDING HIS BID FOR THE 20-24 ELECTION… PAVING THE WAY FOR HARRIS TO BECOME THE DEMOCRATIC PRESIDENTIAL NOMINEE.